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Objectives. We examined the extent of fibrotic changes in the 
left atrium of cardiomyopathic uman hearts and investigated the 
relation of mechanical overload caused by left ventricular dys- 
function to fibrosis of the left atrium. 
Background. Left atrial dysfunction in dilated cardiomyopathy 
may contribute to progression of heart failure. In contrast o 
fibrosis of the left ventricle, atrial fibrosis has not been extensively 
studied in cardiomyopathic hearts. 
Methods. The extent of fibrosis in the left atrium and left 
ventricle was determined by an automatic image analyzer in 38 
autopsied hearts obtained from 9 patients who died of noncardiac 
illness (control group), 16 patients with dilated cardiomyopathy, 6 
patients with hypertrophic cardiomyopathy with features mimick- 
ing dilated cardiomyopathy and 7 patients with a previous myo- 
cardial infarction. Transverse sections were obtained at the upper 
margins of the foramen ovale and left auricle in the left atrium 
and the median level of the left ventricle. 
Results. There were no significant differences in extent of left 
atrial dilation, left ventricular dysfunction or duration of illness 
among the three groups with cardiac disease. Percent area of left 
atrial fibrosis (mean ~- SD) was significantly greater in the 
specimens from patients with dilated cardiomyopathy (13.1 + 
6.1%, p < 0.01) and hypertrophic ardiomyopathy mimicking 
dilated cardiomyopathy (26.5 -+ 9.5%, p < 0.01) than in those 
from patients with an old myocardial infarction (3.8 ± 1.1%). 
Percent area of left ventricular fibrosis in hearts from patients 
with dilated cardiomyopathy (12.9 ± 8.6%) was significantly 
smaller than that in hearts from patients with hypertrophic 
cardiomyopathy mimicking dilated cardiomyopathy (35.8 -+ 
11.9%, p < 0.01) and a previous myocardial infarction (38.4 -+ 
8.0%, p < 0.01). Percent area of atrial fibrosis was significantly 
correlated with left ventricular ejection fraction in the group with 
a previous myocardial infarction but not in the other groups. 
Conclusions. There was a high degree of fibrotic change in the 
left atrium in the groups with dilated cardiomyopathy and hyper- 
trophic cardiomyopathy mimicking dilated cardiomyopathy. Our 
findings suggest that atrial fibrosis in these patients may not have 
been related to mechanical overload of the left atrium but to some 
other, still unknown mechanisms. 
(J Am CoU Cardiol 1995;25:1162-9) 
Cardiac dilation and decreased contractile function are char- 
acteristic of dilated cardiomyopathy (1). Previous studies (2,3) 
have demonstrated that fibrosis of the ventricular wall is 
prominent in dilated cardiomyopathy; however, the correlation 
between the extent of fibrosis and contractile function is 
controversial. Fibrosis primarily contributes to the stiffness of 
the ventricular wall and thus may account for the elevated 
end-diastolic pressure of the left ventricle. In stiff, especially 
failing, hearts, left atrial systolic function may be important for 
ventricular filling during diastole (4,5), and atrial fibrillation or 
flutter can produce atrial failure, with severe detrimental 
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effects on ventricular filling and on the overall pump function 
of the heart (6,7). Triposkiadis et al. (8) reported that depres- 
sion of left atrial contractile function was significantly greater 
in patients with dilated cardiomyopathy than in those with 
aortic valve disease with comparable left ventricular dysfunc- 
tion. However, left atrial tissue from cardiomyopathic hearts 
has not undergone xtensive histologic study (9-14). 
In the present study, we investigated the extent of left atrial 
fibrosis in autopsied hearts from patients with dilated cardiom- 
yopathy and hypertrophic cardiomyopathy with features mim- 
icking dilated cardiomyopathy. In an attempt o clarify the 
effect of mechanical overload on atrial fibrosis, we also studied 
the extent of atrial fibrosis in hearts from patients with a 
previous myocardial infarction with left ventricular dysfunction 
comparable to that seen in cardiomyopathy. 
Methods  
Materials. We studied 38 autopsied hearts: 9 from patients 
who died of noncardiac illness (control group [5 men, 4 
women]); 6 from patients with hypertrophic ardiomyopathy 
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Table 1. Clinical and Pathologic Features of 38 Autopsied Hearts 
Wall Thickness (mm) 
Case Age (yr)/ Heart 
No. Gender Weight (g) LA FW LV FW LVS 
Hypertrophic Cardiomyopathy Mimicking Dilated Cardiomyopathy 
LV LA 
Fibrosis Fibrosis 
(%) (%) 
1 18/M 900 2.1 11 18 
2 47,q z 500 1.8 10 19 
3 17/F 420 2.0 11 9 
4 21/F 530 2.7 12 21 
5 49/F 750 2.5 14 22 
6 21/M 780 2.1 3 7 
Mean 29 647 2.2 10 16 
+SD _+14' +173 _+0.3 _+4 -+6 
18.6 44.8 
30.9 21.6 
29.9 16.6 
45.7 32.4 
51.5 20.8 
38.1 22.5 
35.8 26.5 
• +11.97 _+9.5:~ 
Dilated Cardiomyopathy 
1 361F 500 1.7 10 10 9.6 4.4 
2 51/M 550 2.6 9 10 5.9 5.0 
3 51/M 480 2.1 6 9 4.7 16.4 
4 42/M 480 1.6 10 6 11.3 23.6 
5 63/M 450 2.2 8 10 31.6 21.0 
6 46/M 600 2.1 11 11 15.6 12.6 
7 40/M 390 2.7 11 12 23.5 12.7 
8 36fF 500 1.7 5 6 11.3 13.0 
9 23/M 560 2.4 11 10 16.7 19.6 
10 72/M 610 2.1 11 10 4.9 17.7 
11 48/M 405 2.2 8 9 11.8 19.7 
12 64/M 540 2.0 10 9 0.6 10.5 
13 67/M 590 1.9 10 11 14.4 11.9 
14 65/M 510 1.7 10 11 13.8 12.5 
15 37/F 530 2.3 8 8 3.8 4.5 
16 49/M 940 2.1 11 13 26.9 3.9 
Mean 49 538 2.1 9 10 12.9 13.1 
_+SD _+13 _+117 _+0.3 _+2 _~2 _+8.6 _+6.1§ 
Heart LA Wall LV LA 
Age Weight Thickness Fibrosis Fibrosis 
(yr) (g) (mm) (%) (%) 
Previous Myocardial Infarction (n = 7 [6M/1F]) 
Range 47-75 400-570 1.6-2.6 24.4-51.6 1.9-5.5 
Mean + SD 59 -+ 9 453 _+ 54 2.1 _+ 0.4 38.4 _+ 8.0:~ 3.8 _+ 1.1 
Control Group (n - 9 [5M/4F]) 
Range 43-66 230-310 2.9-3.4 0.4-1.4 0.8-1.8 
Mean - SD 53 _+ 9 286 _+ 29 3.1 _+ 0.1 0.9 - 0.3 1.4 _+ 0.3 
*p < 0.05 versus old myocardial infarction. ?p < 0.01 versus dilated cardiomyopathy. :~p < 0.01 versus dilated 
cardiomyopathy and old myocardial infarction. §p < 0.01 versus old myocardial infarction. F = female; FW = free wall; 
LA = left atrial; LV = left ventricular; LVS = left ventricular septum; M = male. 
mimicking dilated cardiomyopathy (2 men, 4 women); 16 from 
patients with dilated cardiomyopathy (13 men, 3 women); and 
7 from patients with a previous myocardial infarction (6 men, 
1 woman) (Table 1). 
Hypertrophic cardiomyopathy mimicking dilated cardiom- 
yopathy is a form of hypertrophic cardiomyopathy character- 
ized by progressive dilation of the left ventricle in the late stage 
(14-17). The diagnosis of hypertrophic cardiomyopathy mim- 
icking dilated cardiomyopathy was made according to previ- 
ously described criteria (18). In three of the six patients with 
hypertrophic cardiomyopathy mimicking dilated cardiomyop- 
athy, progression from typical hypertrophic ardiomyopathy to 
dilated cardiomyopathy-like f atures was detected by echocar- 
diography. In the remaining three patients, dilated cardiomy- 
opathy was diagnosed on the basis of clinical features, but 
autopsy showed extensive myocardial fiber disarray distributed 
mainly in the ventricular septum. Thus, hypertrophic cardiom- 
yopathy was diagnosed on the basis of histologic findings. This 
diagnosis was also supported by a familial prevalence of 
hypertrophic cardiomyopathy. 
The clinical diagnosis of dilated cardiomyopathy was based 
on the criteria of the World Health Organization (19) for the 
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definition and classification of cardiomyopathies. No diffuse 
disarray of myocytes or marked asymmetric ventricular hyper- 
trophy was observed in specimens from patients with dilated 
eardiomyopathy. A familial prevalence of dilated cardiomyop- 
athy was observed in two patients. 
The mean age of the patients with hypertrophic cardiomy- 
opathy mimicking dilated cardiomyopathy was significantly 
younger than that of patients in the other two groups (p < 0.01 
vs. patients with dilated cardiomyopathy and those with an old 
myocardial infarction). All patients died of severe congestive 
heart failure. No cases of sudden death were included in the 
present study. Mean heart weight was significantly greater in 
the patients with hypertrophic cardiomyopathy mimicking di- 
lated cardiomyopathy than in those with dilated cardiomyop- 
atby (p < 0.05). Mean ratio of septal/free wall thickness was 1.1 
in the group with dilated cardiomyopathy and 1.6 in that with 
hypertrophic cardiomyopathy mimicking dilated cardiomyop- 
athy. The left atrial wall was thin in the three groups with 
cardiac disease compared with the control group (p < 0.05); 
there was no significant difference in thickness among the 
three groups with cardiac disease (Table 1). 
Lumen diameter of the extramural coronary arteries was 
<50% in the groups with hypertrophic cardiomyopathy mim- 
icking dilated cardiomyopathy and dilated cardiomyopathy. In 
the group with myocardial infarction, three patients had triple- 
vessel disease, three had proximal eft anterior descending 
coronary artery disease, and one had left circumflex coronary 
artery disease. All patients had anterior or lateral myocardial 
infarction, or both. They died of incurable severe congestive 
heart failure in the chronic stage. There was no significant 
coronary lumen narrowing in the control group. 
Histologic examination. Left ventricle. The hearts were 
weighed and fixed in 10% formalin and sectioned transversely 
from base to apex at l-cm intervals. A slice from the midlevel 
of the autopsied heart was embedded in paraffin. The whole 
sectioned surface was cut into sections -5-p,m thick on a glass 
slide and stained with hematoxylin-eosin a d Masson's 
triehrome. Each tissue section was divided into anterior, 
lateral, posterior and septal regions. 
Left atrium. After fixation, transverse sections were cut 
from the area just above the left auricle and foramen ovale 
(Fig. 1). After staining with hematoxylin-eosin a d Masson's 
trichrome, each section was divided into anterior, lateral, 
posterior and septal regions. 
The 5-~m thick preparations tained with Masson's 
trichrome were enlarged 10 times with a photographic en- 
larger. Areas that stained blue, indicating fibrosis, were care- 
fully traced with a fine black pen. The percent area of fibrosis 
was measured with an automatic image processing system 
(Olympus Vip-21), as previously described (20,21). 
The percent area of fibrosis in the entire ventricular and 
atrial wall of the transverse slice was obtained by dividing the 
total area of fibrosis by the total tissue area. To determine the 
intramural distribution of fibrosis, the regional percent area of 
fibrosis in the anterior, lateral, posterior and septal walls of the 
left atrium and left ventricle was calculated separately. Papil- 
A 
LA P 
Figure 1. Left, Transverse ctions obtained from area just above the 
left auricle (LAA) and foramen ovale (FO). A = aorta; LA = left 
atrium; MV = mitral valve; P = pulmonary artery; TV = tricuspid 
valve. Right, Schematic diagram of transverse ction of the left atrial 
(LA) wall, divided into anterior (A), lateral (L), posterior (P) and 
septa[ (S) regions. 
lary muscles were excluded from measurement of fibrosis in 
the ventricular section. Endocardium and epicardium were 
excluded from measurement of fibrosis in the atrial section. 
To confirm the accuracy of measurements, we analyzed the 
extent of fibrosis in two transverse sections obtained at 
10-ram intervals from two hearts in each group. In all cases, 
fibrosis was traced and quantified independently b two mor- 
phologists. Measurements varied by <7%. 
ltemodynamic measurements. Hemodynamic measure- 
ments determined by cardiac atheterization, contrast or ra- 
dionuclide left ventriculography and Doppler echocardiogra- 
phy (22) were obtained within 3 months of death. We defined 
the duration of illness as the period from the first episode of 
severe congestive heart failure (New York Heart Association 
functional class III) to death. The duration of illness was not 
significantly different among groups. There were also no 
significant differences in ejection fraction or mitral regurgita- 
tion grade. Left ventricular end-diastolic dimension in the 
group with dilated cardiomyopathy was significantly larger 
than that in the groups with hypertrophic cardiomyopathy 
mimicking dilated cardiomyopathy and previous myocardial 
infarction (p < 0.05, respectively). Left atrial dimension and 
mean pulmonary artery wedge pressure did not differ among 
groups (Table 2). The incidence of atrial fibrillation was 33% 
in the group with hypertrophic cardiomyopathy mimicking 
dilated cardiomyopathy, 12.5% in the group with dilated 
cardiomyopathy and 14% in the group with a previous myo- 
cardial infarction. 
Statistical analysis. Data are expressed as mean value + 
SD. Because of the large variance of differences ineach group, 
nonparametric methods (Wilcoxon test with Bonferroni pro- 
cedure) were used when appropriate; p < 0.05 was considered 
statistically significant. 
Resu l ts  
Left atrial microscopic findings. Figure 2 (top) shows a 
microscopic specimen from the left atrium of a patient with an 
old myocardial infarction. In control hearts and in those from 
patients with a previous myocardial infarction, fibrous tissue 
extending from the perivascular fibrosis was rarely observed 
around the well defined muscle bundles. The extent of fibrosis 
was minimal, and the myocardium showed no particular 
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Table 2. Clinical Course and Hemodynamic Data 
Echocardiographic 
Data 
Family 
History Duration f LVDd LAD mPAWP 
Study Group (+/-) Illness (mo) (mm) (mm) FS (%) (ram Hg) EF (%) MR 
DCM-like HCM (n = 6) 5/1 32 _+ 14 60 + 7* 39 ± 12 13.5 ± 5.4 22 ± 9 20 ± 3 2.0 _+ 0.6 
(n - 5) (n : 5) 
DCM (n = 16) 2/14 34 +_ 19 70 _+ 8 43 _+ 9 13.1 _+ 5.3 18 ± 9 23 ± 6 2.1 ± 1.1 
(n - 14) (n = 15) 
OMI (n = 7) -- 29 + 16 59 ± 8* 40 ± 7 15.6 ± 11.7 25 + 5 27 ± 9 1.3 ± 1.2 
(n = 6) 
*p < 0.05 versus dilated cardiomyopathy (DCM). DCM-like HCM = hypertrophic cardiomyopathy with features mimicking dilated cardiomyopathy; Duration of 
illness = period from functional class lII episode to death; EF - ejection fraction; FS = fractional shortening; LAD = left atrial dimension; LVDd = left ventrieular 
end-diastolic dimension; mPAWP - mean pulmonary, artery wedge pressure; MR = mitral regurgitation (grade 0-4); OMI = old myocardial nfarction; += pres- 
ence; - = absence. 
changes. In hearts with dilated cardiomyopathy, there was a 
diffuse netlike fibrosis within the muscle bundles, with moder- 
ate disruption of bundle structure. The muscle mass was 
relatively well preserved, but some myocardial fibers showed 
vacuolar degeneration and a combination of hypertrophy and 
attenuation (Fig. 2, middle). In contrast, massive fibrosis and 
marked loss of muscle mass were observed in the left atrium of 
hearts with hypertrophic ardiomyopathy mimicking dilated 
cardiomyopathy (Fig. 2, bottom). Muscle bundles were mark- 
edly disrupted or associated with unrecognizable structures 
with occasional vacuolar degeneration and myocardial attenu- 
ation, or both. Almost complete replacement with fibrous 
tissue was seen in the center of the fibrotic area. 
The percent area of fibrosis in a transverse section of the 
entire left atrium was 1.4 + 0.3% in control hearts, 26.5 _+ 
9.5% in hearts with hypertrophic cardiomyopathy mimicking 
dilated cardiomyopathy, 13.1 _+ 6.1% in hearts with dilated 
cardiomyopathy and 3.8 _ 1.1% in those with a previous 
myocardial infarction, significantly greater in hearts with hy- 
pertrophic ardiomyopathy mimicking dilated cardiomyopathy 
than in those with dilated cardiomyopathy (p < 0.01) and a 
previous myocardial infarction (p < 0.01) and significantly 
greater in hearts with dilated cardiomyopathy than in those 
with a previous myocardial infarction (p < 0.01) (Table 1, Fig. 3). 
None of the groups showed any significant regional varia- 
tion in the extent of fibrosis (Fig. 4). 
Percent area of left ventricular fibrosis. The percent area 
of all left ventricular fibrosis in hearts with dilated cardiomy- 
opathy (12.9 _+ 8.6%) was significantly smaller than that in 
hearts with hypertrophic ardiomyopathy mimicking dilated 
cardiomyopathy (35.8 __ 11.9%, p < 0.01) and a previous 
myocardial infarction (38.4 _+ 8.0%, p < 0.01). There was no 
significant regional variation in extent of fibrosis in hearts with 
dilated cardiomyopathy and hearts with hypertrophic cardio- 
myopathy mimicking dilated cardiomyopathy. Percent area of 
left ventricular fibrosis did not correlate with that in the left 
atrium in either group. 
Relation of percent area of left atrial fibrosis to ejection 
fraction. Extent of left atrial fibrosis was significantly corre- 
lated with left ventricular ejection fraction (r = -0.82, p < 
0.05) in hearts with an old myocardial infarction. No correla- 
tion between extent of fibrosis and ejection fraction was 
observed in the other groups (Fig. 5). Because the number of 
patients with chronic atrial fibrillation was small, we could not 
detect any trend in the relation of these two variables in 
patients with versus without sinus rhythm. 
Discuss ion  
Histologic assessment of atrial fibrosis. Previous tudies of 
atrial fibrosis were limited with regard to quantitative assess- 
ment of extent of fibrotic changes (e.g., tissue samples that 
were too small and sampling sites that were limited to the 
endocardium [23] or atrial appendage [24]). Bailey et al. (25) 
observed extensive atrial tissue fibrosis in patients with chronic 
atrial fibrillation, but this may lead to an incorrect quantitative 
correlation between extent of fibrotic changes and duration of 
atrial fibrillation because biopsied tissue samples may not 
reflect histologic changes in the entire atrium. Histologic 
examination of entire transverse sections is necessary to eval- 
uate the distribution and extent of fibrosis of the myocardium. 
To our knowledge, the present study is the first to quantita- 
tively assess the extent of fibrosis on transverse slices of the 
entire left atrium using an automatic image analyzer. We 
tested the reliability of using percent fibrosis as an index of the 
extent of fibrotic changes in the whole atrium by comparing the 
percent fibrosis in two transverse slices obtained at 10-mm 
intervals from two hearts in each group. Percent fibrosis was 
comparable in tissue slices obtained from the same heart, 
suggesting that the percent fibrosis observed in the transverse 
slice of the atrium represented the extent of fibrotic changes in 
the whole atrium. We also confirmed that our measurements 
of fibrosis were reproducible in the present study. Thus, 
percent fibrosis appeared to be a reliable index of fibrotic 
changes in atrial tissue. 
Fibrosis of the left atrial wall. Aging and mechanical 
overload are believed to be two major causes of fibrosis in the 
left atrium. The distribution of fibrosis and adipose tissue in 
the atrial wall has been found to increase with age, whereas the 
proportion of muscle fibers decreases (26). In the present 
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Figure 2. Left atrial wall specimens from (top) a patient with an old 
myocardial infarction showing perivascular fibrosis and compact myo- 
cardium in muscle bundles; middle a patient with dilated cardiomyop- 
athy showing severe interstitial fibrosis and moderate muscle bundle 
disruption; and bottom a patient with hypertrophic cardiomyopathy 
with features mimicking dilated cardiomyopathy s owing complete r - 
placement fibrosis and marked muscle bundle disruption. Hematoxylin- 
eosin and Masson's trichrome stain, x 170, reduced by 30%. 
study, patients with dilated cardiomyopathy and hypertrophic 
cardiomyopathy mimicking dilated cardiomyopathy were much 
younger than those with an old myocardial infarction. How- 
ever, percent fibrosis was significantly greater in patients with 
dilated cardiomyopathy and hypertrophic ardiomyopathy 
(%) 
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Figure 3. Percent area of left atrial (LA) fibrosis in DCM-like HCM = 
hypertrophic cardiomyopathy with features mimicking dilated car- 
diomyopathy; DCM = dilated cardiomyopathy; OMI = old myocardial 
infarction. Vertical bars and open circles = mean _+ SD. 
mimicking dilated cardiomyopathy t an in those with a previ- 
ous myocardial infarction, suggesting that the marked fibrosis 
in patients with dilated cardiomyopathy and hypertrophic 
cardiomyopathy mimicking dilated cardiomyopathy may be 
related to factors other than aging. Mechanical overload may 
account primarily for fibrosis of atrial tissue. Triposkiadis et al. 
(8) reported that left atrial systolic function is more impaired 
in patients with dilated cardiomyopathy t an in those with left 
ventricular dysfunction caused by valvular abnormalities, de- 
spite comparable mechanical loads to the atrium in both 
diseases. This finding suggests that mechanical overload itself 
does not cause marked fibrotic changes in the atrium. This 
hypothesis i  supported by the findings of Bailey et al. (25), 
who observed minimal fibrotic changes in the left atrium in 
patients with nonrheumatic mitral valvular abnormalities, uch 
as idiopathic cardiomyopathy and papillary muscle dysfunc- 
tion. In our study, there was a close correlation between left 
ventricular ejection fraction and percent area of atrial fibrosis 
in patients with an old myocardial infarction. Although we did 
not determine l ft atrial pressures in our patients, it is possible 
that the mechanical load of the left atrium may be inversely 
correlated with left ventricular ejection fraction. If so, the 
extent of atrial fibrosis in the group with an old myocardial 
infarction may reflect he mechanical load of the atrial muscle. 
However, the load-dependent fibrotic changes in the group 
with an old myocardial infarction were significantly smaller 
than those observed in patients with dilated cardiomyopathy 
and hypertrophic cardiomyopathy mimicking dilated cardiom- 
yopathy, indicating that causes other than mechanical overload 
may be primarily responsible for fibrotic changes in idiopathic 
myopathy. 
Unrecognized viral myocarditis may be an underlying cause 
of dilated cardiomyopathy in a substantially arge number of 
patients (27). Bowles et al. (28) reported that Coxsaclde B 
virus RNA was frequently observed in biopsied ventricular 
tissue samples from patients with dilated cardiomyopathy. 
Matsumori et al. (29) also reported that viral myocarditis 
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Figure 4. Regional distribution of left atrial (LA) 
fibrosis. Vertical bars and open circles = mean + SD. 
Abbreviations a in Figures 1 and 3. 
DCM-like HCM 
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occurred in both the atrium and ventricle in an experimental 
animal model. Thus, it is likely that the marked fibrotic 
changes in patients with idiopathic cardiomyopathy are re- 
lated, in part, to previous viral myocarditis. Although there was 
no correlation between fibrotic changes in the ventricle and 
atrium in individual patients, the high prevalence of myocar- 
dial fibrosis observed in patients with idiopathic ardiomyop- 
athy strongly supports this hypothesis. 
Fibrosis in patients with dilated cardiomyopathy and hy- 
pertrophic cardiomyopathy mimicking dilated cardiomyopa. 
thy. Percent fibrosis of the left ventricle was significantly 
higher in patients with hypertrophic cardiomyopathy mimick- 
ing dilated cardiomyopathy than in those with dilated cardiom- 
yopathy (35.8% vs. 12.9%, p < 0.01) despite comparable l ft 
ventricular ejection fractions and intervals from the develop- 
ment of heart failure symptoms to death. Our findings in 
patients with hypertrophic cardiomyopathy mimicking dilated 
cardiomyopathy are consistent with those previously reported 
(14). A previous tudy (30) suggested that the transition from 
hypertrophic cardiomyopathy to hypertrophic cardiomyopathy 
mimicking dilated cardiomyopathy is accompanied by an in- 
crease in ventricular fibrosis. Spirito et al. (31) reported that 
5% to 10% of patients with hypertrophic cardiomyopathy show 
progressive thinning of the left ventricular wall and dilation of 
the left ventricular cavity. This phenomenon has been classified 
as hypertrophic cardiomyopathy mimicking dilated cardiomy- 
opathy (18), which is characterized by extensive left ventricular 
myocardial fibrosis. Our findings in the hearts from the group 
with an old myocardial infarction suggest hat fibrotic change 
itself does not cause ventricular dilation, that is, remodeling of 
the left ventricle. In cardiomyopathic Syrian hamsters, left 
ventricular dilation and wall thinning were associated with 
increased collagenase activity. This degradation of collagen 
may have caused remodeling of the ventricle (32). Such a 
biochemical mechanism ay be present in patients with hyper- 
trophic cardiomyopathy mimicking dilated cardiomyopathy, 
although there is no direct evidence to support his hypothesis. 
Myocardial ischemia may also be responsible for the tran- 
sition from hypertrophic ardiomyopathy to hypertrophic ar- 
diomyopathy mimicking dilated cardiomyopathy because abnor- 
mal myocardial structures, uch as disarray (1438,31,33,34), can 
impair the coronary microvascular vasodilatory response (35). 
However, this hypothesis may not be plausible in the atrium 
because the atrial chamber, which is like a low pressure 
reservoir, is not susceptible to ischemia. Atrial infarction is 
extremely rare (36,37). In the present study, three patients 
with an old myocardial infarction had complete obstruction 
of the sinus node and atrial circumflex arteries in the left 
atrium. However, none of these patients had signs of left 
atrial infarction, and atrial fibrosis was minimal. There is often 
a family link in patients who progress from hypertrophic 
cardiomyopathy to hypertrophic ardiomyopathy mimicking 
dilated cardiomyopathy (14), suggesting that genetic factors 
may be involved. The tissue renin-angiotensin system and 
growth factors, such as transforming rowth factor-beta I and 
basic fibrinogen growth factor and cytokines may also play a 
major role in both ventricular and atrial fibrosis, although we 
observed no correlation between ventricular and atrial fibrosis. 
Sympathetic activity may also modulate these processes (38). 
Investigation of neurohormonal nd immunologic alterations 
in hypertrophic cardiomyopathy mimicking dilated cardiomy- 
opathy is needed to clarify the underlying mechanism of 
myocardial fibrosis. 
Limitation of the study. A major limitation of this study is 
that we examined autopsied hearts, and, thus, the present 
results may represent histologic hanges in severely ill patients 
only. However, the mean percent area of fibrosis in the 
ventricle in patients with dilated cardiomyopathy (12.9 _+ 
8.6%) was consistent with that found in previous tudies based 
on biopsied samples, indicating that the population bias may 
not be excessively arge. 
The hemodynamic data in the present study were obtained 
within 3 months of death, and pulmonary artery wedge pres- 
sures were obtained within 6 months of death, complicating the 
relation between hemodynamic data and histologic changes at 
autopsy. However, the interval between the hemodynamic and 
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Figure 5. Relation of percent area of left atrial (LA) fibrosis to left 
ventricular ejection fraction in patients with hypertrophic cardiomyop- 
athy mimicking dilated cardiomyopathy (top) (r = -0.815, p = NS); 
dilated cardiomyopathy (middle) (r = 0.516, p = NS); and an old 
myocardial infarction (bottom) (r = -0.815, p < 0.05). Solid circles = 
mitral regurgitation grade 1 to 2; open circles = mitral regurgitation 
grade 3 to 4. tChronic atrial fibrillation. 
the autopsy studies was comparable among the three study 
groups, and, thus, the difference among groups may be mini- 
mal. We could not reach any conclusion as to whether atrial 
fibrosis increases the incidince of atrial fibrillation because the 
number of patients with chronic atrial fibrillation was minimal. 
Nevertheless, the incidence of atrial fibrillation was highest in 
patients with hypertrophic cardiomyopathy mimicking dilated 
cardiomyopathy, indicating that extensive atrial fibrosis may 
increase the incidence of nonsinus atrial rhythm. Despite these 
limitations, to our knowledge the present study is the first to 
demonstrate a high prevalence of atrial fibrosis in patients with 
dilated cardiomyopathy, especially those with hypertrophic 
cardiomyopathy mimicking dilated cardiomyopathy. 
We thank Takashi Shimazu, Shujiro Kubori, Shigeru Salto, Masami lmakita and 
Hatsue Ueda for their advice. 
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